Prospect: information for the user
ABILIFY 5 mg tablets
ABILIFY 10 mg tablets
ABILIFY 15 mg tablets
ABILIFY 30 mg tablets
aripiprazol
Read this prospect carefully before starting to take this medicine, as it contains important information for you.
1. What is ABILIFY and for what it is used
2. What you need to know before starting to take ABILIFY
3. How to take ABILIFY
4. Possible adverse effects
5. Storage of ABILIFY
6. Contents of the package and additional information
ABILIFY contains the active ingredient aripiprazol and belongs to a group of medicines called antipsychotics. It is used to treat adults and adolescents 15 years of age or older who suffer from a condition characterized by symptoms such as hearing, seeing, and feeling things that do not exist, distrust, false beliefs, incoherent speech, and monotony of emotional and behavioral state. People in this state may also feel depressed, guilty, restless, or tense.
ABILIFY is used to treat adults and adolescents 13 years of age or older who suffer from a disorder characterized by symptoms such as feeling euphoric, having excessive energy, needing to sleep much less than usual, speaking very quickly with flight of ideas, and sometimes, severe irritability. In adults, it also prevents this situation in patients who have responded to treatment with ABILIFY.
Do not take ABILIFY
Warnings and precautions
Consult your doctor before starting to take ABILIFY.
Cases of patients experiencing suicidal thoughts and behaviors during treatment with aripiprazole have been reported. Inform your doctor immediately if you have thoughts or feelings of harming yourself.
Before starting treatment with ABILIFY, tell your doctor if you have:
If you notice that you are gaining weight, developing unusual movements, experiencing drowsiness that interferes with your daily activities, having difficulty swallowing, or experiencing allergic symptoms, please inform your doctor.
If you have dementia (loss of memory and other mental abilities), you or the person caring for you or a family member should inform your doctor if you have ever had a stroke or "mini" stroke.
Tell your doctor immediately if you have thoughts or feelings of harming yourself. Cases of patients experiencing suicidal thoughts and behaviors during treatment with aripiprazole have been reported.
Tell your doctor immediately if you notice numbness or stiffness of the muscles with high fever, sweating, altered mental state, or a very fast or irregular heartbeat.
Inform your doctor if you, your family, or caregiver notice that you are developing impulses or urges to behave in an unusual way in you and cannot resist the impulse, instinct, or temptation to carry out certain activities that may harm you or others. This is known as impulse control disorder and may include behaviors such as addiction to gambling, excessive eating or spending, abnormally high sex drive, or excessive concern about an increase in sexual thoughts and feelings.
Your doctor may consider adjusting or interrupting the dose.
Aripiprazole may cause drowsiness, a drop in blood pressure when standing up, dizziness, and changes in the ability to move and maintain balance, which could cause falls. You should be careful, especially if you are an elderly patient or have weakness.
Children and adolescents
Do not use this medicine in children and adolescents under 13 years old. Its safety and effectiveness in these patients are unknown.
Other medicines and ABILIFY
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medicine, including over-the-counter medicines.
Medicines that lower blood pressure: ABILIFY may increase the effect of medicines used to lower blood pressure. Make sure to inform your doctor if you are using any blood pressure-lowering medication.
If you are taking ABILIFY with any other medicine, it may mean that your doctor needs to change your dose of ABILIFY or the dose of the other medicines. It is especially important to mention to your doctor if you are taking:
These medicines may increase the risk of adverse effects or reduce the effect of ABILIFY; if you observe any unusual symptoms when taking any of these medicines at the same time as ABILIFY, you should inform your doctor.
Medicines that increase serotonin levels are generally used to treat diseases that include depression, generalized anxiety disorder, obsessive-compulsive disorder (OCD), and social phobia, as well as migraine and pain:
These medicines may increase the risk of adverse effects; if you observe any unusual symptoms when taking any of these medicines at the same time as ABILIFY, you should inform your doctor.
ABILIFY with food, drinks, and alcohol
This medicine can be taken regardless of meals.
Alcohol consumption should be avoided.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, or think you may be pregnant, or are planning to become pregnant, consult your doctor or pharmacist before using this medicine.
The following symptoms may occur in newborn babies, from mothers who have been treated with ABILIFY in the last trimester of pregnancy (last three months of pregnancy): tremors, stiffness, and/or muscle weakness, drowsiness, agitation, breathing problems, and difficulty feeding. If your baby develops any of these symptoms, contact your doctor.
If you are taking ABILIFY, your doctor will discuss with you whether you should breastfeed your baby, considering the benefit of your treatment and the benefit of breastfeeding for your baby. If you are being treated with ABILIFY, do not breastfeed. Talk to your doctor about the best way to feed your baby if you are taking this medicine.
Driving and operating machinery
During treatment with this medicine, dizziness and vision problems (see section 4) may occur. This should be taken into account when requiring maximum attention, for example, when driving or operating machinery.
ABILIFY contains lactose
If your doctor has told you that you have a lactose intolerance, consult with him before taking this medicine.
Follow exactly the administration instructions of this medication indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
The recommended dose for adults is 15 mg once a day.However, your doctor may prescribe lower and higher doses up to a maximum of 30 mg once a day.
Use in children and adolescents
This medication should be initiated with the oral solution (liquid) at a low dose.
The dose can be gradually increased tothe recommended dose for adolescents of 10 mg once a day. However, your doctor may prescribe lower or higher doses up to a maximum of 30 mg once a day.
If you estimate that the action of ABILIFY is too strong or weak, inform your doctor or pharmacist.
Try to take ABILIFY at the same time every day. It does not matter if you take it with or without food. Take the tablets with water and swallow them whole.
Even if you feel better, do not alter or interrupt the daily dose of ABILIFY without consulting your doctor first.
If you take more ABILIFY than you should
If you realize you have taken more ABILIFY than your doctor recommended (or if someone else has taken part of your ABILIFY), contact your doctor immediately. If you cannot communicate with your doctor, go to the nearest hospital and bring the packaging with you.
Patients who have taken too much aripiprazol have experienced the following symptoms:
Other symptoms may include:
Contact your doctor or nearest hospital immediately if you experience any of the above symptoms.
If you forget to take ABILIFY
If you forget a dose, take the missed dose as soon as you remember, but do not take a double dose to compensate for the missed dose.
If you interrupt treatment with ABILIFY
Do not stop treatment just because you feel better. It is essential that you continue taking ABILIFY for the time your doctor has indicated.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
Frequent side effects (may affect up to 1 in 10 patients):
Rare side effects (may affect up to 1 in 100 patients):
The following side effects have been reported during the post-marketing phase of oral aripiprazole, but the frequency of occurrence is unknown:
Inform your doctor if you experience any of these behaviors; he will explain how to manage or reduce the symptoms.
In elderly patients with dementia, there have been reported a higher number of fatal cases while taking aripiprazole. Additionally, cases of stroke or "mini" stroke have been reported.
Other side effects in children and adolescents
Adolescents aged 13 years or older experienced side effects similar in frequency and type to those of adults, except for drowsiness, involuntary spasms or contractions, restlessness, and fatigue, which were very frequent (affects more than 1 in 10 patients), and upper abdominal pain, dry mouth, increased heart rate, weight gain, increased appetite, muscle fasciculations, involuntary movements of the limbs, and dizziness, especially when getting up from lying or sitting, which were frequent (affects up to 1 in 10 patients).
Reporting of side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this prospectus. You can also report them directly through thenational notification system included in the Appendix V.Mediante the reporting of side effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
Store in the original packaging to protect it from moisture.
Medications should not be disposed of through drains or trash. Ask your pharmacist how to dispose of the packaging and medications that you no longer need. This will help protect the environment.
ABILIFY Composition
Each tablet contains 5 mg of aripiprazol.
Each tablet contains 10 mg of aripiprazol.
Each tablet contains 15 mg of aripiprazol.
Each tablet contains 30 mg of aripiprazol.
Tablet Coating
ABILIFY 5 mg tablets: aluminium lake of indigo carmine (E 132)
ABILIFY 10 mg tablets: iron oxide red (E 172)
ABILIFY 15 mg tablets: yellow iron oxide (E 172)
ABILIFY 30 mg tablets: iron oxide red (E 172)
Appearance of ABILIFY and packaging contents
ABILIFY 5 mg tablets are rectangular and blue, engraved with “A-007” and “5” on one side.
ABILIFY 10 mg tablets are rectangular and pink, engraved with “A-008” and “10” on one side.
ABILIFY 15 mg tablets are round and yellow, engraved with “A-009” and “15” on one side.
ABILIFY 30 mg tablets are round and pink, engraved with “A-011” and “30” on one side.
ABILIFY is presented in single-dose blisters packaged in boxes containing 14 × 1, 28 × 1, 49 × 1, 56 × 1, or 98 × 1 tablets.
Only some packaging sizes may be marketed.
Marketing Authorization Holder
Otsuka Pharmaceutical Netherlands B.V.
Herikerbergweg 292
1101 CT, Amsterdam
Netherlands
Responsible for Manufacturing
Elaiapharm
2881 Route des Crêtes, Z.I. Les Bouilides-Sophia Antipolis,
06560 Valbonne
France
For more information about this medication, please contact the local representative of the marketing authorization holder.
Belgium/Belgique/Belgien Otsuka Pharmaceutical Netherlands B.V. Tel: +31 (0) 20 85 46 555 | Lithuania Otsuka Pharmaceutical Netherlands B.V. Tel: +31 (0) 20 85 46 555 |
... Otsuka Pharmaceutical Netherlands B.V. Tel: +31 (0) 20 85 46 555 | Luxembourg/Luxemburg Otsuka Pharmaceutical Netherlands B.V. Tel: +31 (0) 20 85 46 555 |
Czech Republic Otsuka Pharmaceutical Netherlands B.V. Tel: +31 (0) 20 85 46 555 | Hungary Otsuka Pharmaceutical Netherlands B.V. Tel: +31 (0) 20 85 46 555 |
Denmark Otsuka Pharma Scandinavia AB Tlf: +46 (0) 8 545 286 60 | Malta Otsuka Pharmaceutical Netherlands B.V. Tel: +31 (0) 20 85 46 555 |
Germany Otsuka Pharma GmbH Tel: +49 (0) 69 1700 860 | Netherlands Otsuka Pharmaceutical Netherlands B.V. Tel: +31 (0) 20 85 46 555 |
Estonia Otsuka Pharmaceutical Netherlands B.V. Tel: +31 (0) 20 85 46 555 | Norway Otsuka Pharma Scandinavia AB Tlf: +46 (0) 8 545 286 60 |
Greece Otsuka Pharmaceutical Netherlands B.V. Tel: +31 (0) 20 85 46 555 | Austria Otsuka Pharmaceutical Netherlands B.V. Tel: +31 (0) 20 85 46 555 |
Spain Otsuka Pharmaceutical, S.A. Tel: +34 93 550 01 00 | Poland Otsuka Pharmaceutical Netherlands B.V. Tel: +31 (0) 20 85 46 555 |
France Otsuka Pharmaceutical France SAS Tél: +33 (0)1 47 08 00 00 | Portugal Lundbeck Portugal Lda Tel: +351 (0) 21 00 45 900 |
Croatia Otsuka Pharmaceutical Netherlands B.V. Tel: +31 (0) 20 85 46 555 | Romania Otsuka Pharmaceutical Netherlands B.V. Tel: +31 (0) 20 85 46 555 |
Ireland Otsuka Pharmaceutical Netherlands B.V. Tel: +31 (0) 20 85 46 555 | Slovenia Otsuka Pharmaceutical Netherlands B.V. Tel: +31 (0) 20 85 46 555 |
Iceland Vistor hf. Sími: +354 (0) 535 7000 | Slovakia Otsuka Pharmaceutical Netherlands B.V. Tel: +31 (0) 20 85 46 555 |
Italy Otsuka Pharmaceutical Italy S.r.l. Tel: +39 (0) 2 0063 2710 | Finland/Suomi Otsuka Pharma Scandinavia AB Puh/Tel: +46 (0) 8 545 286 60 |
Cyprus Otsuka Pharmaceutical Netherlands B.V. Tel: +31 (0) 20 85 46 555 | Sweden Otsuka Pharma Scandinavia AB Tel: +46 (0) 8 545 286 60 |
Lithuania Otsuka Pharmaceutical Netherlands B.V. Tel: +31 (0) 20 85 46 555 | United Kingdom Otsuka Pharmaceuticals (UK) Ltd. Tel: +44 (0) 203 747 5300 |
Last review date of this leaflet: {MM/AAAA}
Other sources of information
Further information on this medication is available on the website of the European Medicines Agency:http://www.ema.europa.eu.
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.